What is Test License to Import Medical Devices for Testing Purpose (MD 17)
A Test License (Form MD-17) under the Medical Devices Rules, 2017 permits the import of medical devices in limited quantities for testing, evaluation, clinical investigation, demonstration, or training purposes in India. The application is submitted to CDSCO through the prescribed process under MDR 2017. This License is intended only for non-commercial use and does not permit sale or commercial distribution of the medical device. MD-17 helps companies conduct testing, research, validation, and regulatory evaluation activities before obtaining commercial import approval.
When Do You Need Clinical Investigation Import Support?
Support for importing devices for trials, studies, demonstrations, and regulatory testing in India.
-
Importing devices for clinical investigation or trials
-
Conducting performance evaluation studies
-
Importing samples for demonstration or training
-
Testing new or modified medical devices
-
Bringing devices for regulatory submission support data
-
Importing before full commercialization approval (where applicable)
-
Strict justification of quantity required for testing
-
Detailed protocol and study documentation requirement
-
Coordination between foreign manufacturer and Indian applicant
-
Delays due to incomplete technical documentation
-
Device classification ambiguity under MDR 2017
-
Additional regulatory assessment requirements may apply for high-risk (Class C & D) devices
-
Review timelines depend on documentation and CDSCO assessment
Our Approach and What You Will Get
Support for regulatory pathway assessment, import justification, dossier preparation, and CDSCO submission follow-up.
-
Regulatory pathway assessment (device classification & intent)
-
Preparation of justification note for import quantity
-
Drafting and compilation of MD-17 application dossier
-
Alignment with CDSCO expectations & checklist compliance
-
Support in technical document review (IFU, specs, COA, etc.)
-
End-to-end coordination with authority till approval
-
MD-17 application form preparation
-
Device classification confirmation
-
Import justification document
-
Covering letter for CDSCO submission
-
Checklist-compliant documentation set
-
Technical document review report
-
Regulatory gap assessment (if applicable)
-
Submission support & follow-up assistance
Why Choose Tacit Medtek and Case Example
Expertise in CDSCO and MDR 2017 compliance, with end-to-end support for MD-17 applications, documentation, and regulatory coordination.
-
Expertise in CDSCO & MDR 2017 compliance
-
Complete MD-17 application support
-
Device classification & import justification assistance
-
Technical dossier preparation & review
-
SUGAM portal filing & coordination
-
Error-free, audit-ready documentation
-
Reduced regulatory queries & delays
-
End-to-end application tracking
-
Support for MD-15 Import License transition
-
Guidance for shifting to commercial import or manufacturing
-
Challenge: An Indian distributor planned to import a Class B medical device for internal testing and training purposes but faced rejection risks due to improper documentation and unclear end-use justification. They were also unsure about the correct regulatory pathway under CDSCO.
-
Our Approach: Evaluated the intended use and confirmed eligibility under MD-17 provisions. Refined the end-use justification with clear details on testing and training activities. Reviewed and corrected documentation including authorization letters and device details. Prepared and submitted a complete MD-17 application with proper labelling compliance. Coordinated with CDSCO and resolved queries without delays.
-
Outcome: The client successfully obtained MD-17 approval after completion of CDSCO review and submission requirements, enabling smooth import of devices for testing and training purposes in India.
FAQ
Frequently Asked Questions
Medical devices imported or manufactured under MD-13 or MD-17 are intended only for clinical investigation, testing, evaluation, demonstration, or training purposes and are not permitted for commercial sale or distribution.
The risk classification mentioned in a test License application represents the proposed classification submitted by the applicant. Final classification for market authorization is subject to applicable CDSCO classification requirements under MDR 2017.
Under MDR 2017, Form MD-13 is used for manufacturing test Licenses and Form MD-17 is used for import test Licenses related to clinical investigation, testing, evaluation, demonstration, or training purposes.
Enquire Now
Fill in the form and our team will get back to you shortly.
Reach our regulatory experts directly.